Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malaria Falciparum”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02313376
What this trial is testing

Safety, Attenuation and Immunogenicity of GAP3KO Administered Via A Stephensi Mosquitoes

Who this might be right for
Malaria
Seattle Children's Hospital 10
Testing effectiveness (Phase 2)Study completedNCT05829187
What this trial is testing

Momordica Charantia and Dihydroartemisinin-piperaquined-primaquine for Uncomplicated Plasmodium Falciparum Malaria Patients in Southwest Sumba Regency

Who this might be right for
Uncomplicated Plasmodium Falciparum
Syamsudin Abdillah,Ph.D, Pharm D 36
Testing effectiveness (Phase 2)Study completedNCT04546633
What this trial is testing

Efficacy, Safety and Tolerability of KAF156 in Combination With Lumefantrine Solid Dispersion Formulation (LUM-SDF) in Pediatric Population With Uncomplicated Plasmodium Falciparum Malaria

Who this might be right for
Uncomplicated Plasmodium Falciparum Malaria
Novartis Pharmaceuticals 295
Early research (Phase 1)Study completedNCT02237586
What this trial is testing

Effect of Plasmodium Falciparum Exposure and Sickle Cell Trait on Infection Rates and Kinetics After IV Administration of PfSPZ Challenge

Who this might be right for
Plasmodium Falciparum MalariaMalaria
Sanaria Inc. 25
Not applicableStudy completedNCT01567423
What this trial is testing

Efficacy Study of Amodiaquine-Artesunate and Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria

Who this might be right for
Malaria, Falciparum
Epicentre 301
Large-scale testing (Phase 3)Study completedNCT04147546
What this trial is testing

Additional Screening With Sensitives RDTs and Malaria

Who this might be right for
Plasmodium Falciparum MalariaMalaria Diagnosis
Institut de Recherche en Sciences de la Sante, Burkina Faso 340
Testing effectiveness (Phase 2)Study completedNCT00460525
What this trial is testing

Phase II AMA-1 Malaria Vaccine FMP2.1/AS02A Trial in Mali

Who this might be right for
Plasmodium Falciparum Malaria
U.S. Army Medical Research and Development Command 400
Early research (Phase 1)Looking for participantsNCT07011511
What this trial is testing

Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of LAI MMV055 Alone and in Combination With MMV371 in Healthy Participants

Who this might be right for
Malaria, Falciparum
Medicines for Malaria Venture 72
Early research (Phase 1)Ended earlyNCT00126971
What this trial is testing

Chlorproguanil-Dapsone in Pregnant Women

Who this might be right for
Malaria
Centers for Disease Control and Prevention 132
Testing effectiveness (Phase 2)Study completedNCT05400655
What this trial is testing

Anti-malaria MAb in Kenyan Children

Who this might be right for
Plasmodium Falciparum InfectionMalaria
National Institute of Allergy and Infectious Diseases (NIAID) 912
Not applicableStudy completedNCT04182126
What this trial is testing

Adaptive Interventions for Optimizing Malaria Control: a Cluster-Randomized SMART Trial

Who this might be right for
LLIN, PBO LLIN, IRS, Larviciding
University of California, Irvine 122,872
Testing effectiveness (Phase 2)Study completedNCT01031524
What this trial is testing

Trial to Assess the Efficacy of Malaria Vaccine PfCS 102

Who this might be right for
Plasmodium Falciparum Malaria
Swiss Tropical & Public Health Institute 16
Not applicableStudy completedNCT00346346
What this trial is testing

Analysis of the Immune Response to the Malaria Parasite in Mali, West Africa

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 237
Post-approval studies (Phase 4)Study completedNCT00935688
What this trial is testing

Examination of ACT Implementation in a Vivax / Falciparum Co-endemic Area

Who this might be right for
MalariaFever
London School of Hygiene and Tropical Medicine 4,200
Large-scale testing (Phase 3)Study completedNCT01136850
What this trial is testing

Intermittent Preventive Treatment With Azithromycin-containing Regimens in Pregnant Women in Papua New Guinea

Who this might be right for
Malaria in PregnancySexually Transmitted InfectionsAnaemia
University of Melbourne 2,793
Testing effectiveness (Phase 2)Study completedNCT07060508
What this trial is testing

L9LS in Women of Childbearing Potential in Mali

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 279
Post-approval studies (Phase 4)Study completedNCT00808951
What this trial is testing

In Vivo and in Vitro Efficacy of Antimalarial Treatments in Children in Burkina Faso

Who this might be right for
Malaria
Centre Muraz 440
Early research (Phase 1)Not Yet RecruitingNCT06293339
What this trial is testing

Durability of Protection After Single Immunisation With GA2 Sporozoites (CoGA-Rechallenge)

Who this might be right for
Malaria,Falciparum
Leiden University Medical Center 14
Testing effectiveness (Phase 2)Ended earlyNCT02573857
What this trial is testing

Characterise the Antimalarial and Transmission Blocking Activity of a Single Dose of DSM265 or OZ439 in Healthy Subjects With Induced Blood Stage Plasmodium Falciparum or Plasmodium Vivax Infection

Who this might be right for
Malaria
Medicines for Malaria Venture 16
Early research (Phase 1)Study completedNCT02661373
What this trial is testing

First-in-Human Study of an Oral Plasmodium Falciparum Plasma Membrane Protein Inhibitor

Who this might be right for
Malaria
St. Jude Children's Research Hospital 44
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation